FDA Approves Incyte's Zynyz™ (Retifanlimab-Dlwr) For The Treatment Of Metastatic Or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC)Details >
FDA Approves Novartis' Tafinlar + Mekinist for Pediatric Patients with BRAF V600E Low-Grade Glioma, the Most Common Pediatric Brain CancerDetails >
HHS Releases Initial Guidance for Historic Medicare Drug Price Negotiation Program for Price Applicability Year 2026
For the first time, Medicare will be able to negotiate prices directly with drug companies, ensuring lower prices on some of the costliest prescription drugs.Details >
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!